GLP-1 receptor expression beyond appetite: heart and brain tissue
GLP-1 is often described as an appetite signal. Receptor expression data from cardiac and brain tissue suggests the signal reaches much further.
A common shorthand says GLP-1 peptides only affect appetite. That framing is out of date. Where a peptide can act depends on where its receptor is expressed, and receptor expression data from cardiac and brain tissue tells a broader story.
Why receptor maps matter
A peptide is a signal, and a signal only has meaning where a receptor is present to read it. Mapping which tissues express the GLP-1 receptor is therefore the first step in understanding which systems the peptide can reach. A receptor found only in the gut and pancreas would support the appetite-only view. A receptor found in the heart and the brain does not.
Expression data answers a specific question: is the receptor there, and in which cells. It does not on its own show what the signal does once it binds. That distinction keeps receptor maps useful without overstating them.
Cardiac tissue
Baggio and colleagues, writing in Endocrinology in 2018, examined GLP-1 receptor expression in cardiac tissue. Finding the receptor in heart tissue places cardiac signaling within the scope of GLP-1 research, alongside appetite.
Brain tissue
Cork and colleagues, writing in Molecular Metabolism in 2015, examined GLP-1 receptor expression in the brain. Mapping the receptor in neural tissue moves the question from what happens in the gut to which brain circuits can receive the signal directly.
What this changes for researchers
Taken together, the two lines of expression data argue for viewing GLP-1 as a multi-tissue signaling system. Studies that measure only food intake or body weight capture one part of that system. Cardiac and neural endpoints are a separate set of questions, and the receptor data is the reason they are worth asking.